Given how unbelievably badly the “Omicron specific” boosters are performing, and the ongoing, umm, issue with all-cause mortality in the mRNA countries…
Is it possible that Pfizer plans to price their mRNA shots at $110 or more a jab going forward to DISCOURAGE widespread use?
Insurers might suck up paying $20 a shot for a zero-efficacy vaccine for 150 million people. In the American medical system, $3 billion is barely a rounding error.
But at $120, the cost would be $18 billion, more than insurers spent on any other drug in 2021. At that spending level, insurers will start to fight; they may well balk at paying without (currently non-existent) evidence that the boosters are useful.
In other words, is the pricing a backdoor way to withdraw the shots?